Chien-Te Kent Tseng (Chien-Te K Tseng, Chien-Te Tseng)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Gas Chromatography Mass Spectrometry

Respiratory Syndrome Coronavirus

Top Venues

Science translational medicine

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, Puja Bhavesh Patel, Daniel Fernández, Yan Wu, Chenzhou Hao, Chieh-Wen Lo, Marwah Karim, Lin Ning, Aimee Beck, Panatda Saenkham-Huntsinger, Vivian Tat, Aleksandra K Drelich, Bi-Hung Peng, Shirit Einav, Chien-Te Kent Tseng, Catherine A Blish, Michael Z Lin
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Science translational medicine 16 (738) (2024)
Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, Puja Bhavesh Patel, Daniel Fernández, Yan Wu, Chenzhou Hao, Chieh-Wen Lo, Marwah Karim, Lin Ning, Aimee Beck, Panatda Saenkham-Huntsinger, Vivian Tat, Aleksandra K Drelich, Bi-Hung Peng, Shirit Einav, Chien-Te Kent Tseng, Catherine A Blish, Michael Z Lin
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Science translational medicine 16 (738) (2024)
Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, Puja Bhavesh Patel, Daniel Fernández, Yan Wu, Chenzhou Hao, Chieh-Wen Lo, Marwah Karim, Lin Ning, Aimee Beck, Panatda Saenkham-Huntsinger, Vivian Tat, Aleksandra K Drelich, Bi-Hung Peng, Shirit Einav, Chien-Te Kent Tseng, Catherine A Blish, Michael Z Lin
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Science translational medicine 16 (738) (2024)
Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, Puja Bhavesh Patel, Daniel Fernández, Yan Wu, Chenzhou Hao, Chieh-Wen Lo, Marwah Karim, Lin Ning, Aimee Beck, Panatda Saenkham-Huntsinger, Vivian Tat, Aleksandra K Drelich, Bi-Hung Peng, Shirit Einav, Chien-Te Kent Tseng, Catherine A Blish, Michael Z Lin
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Science translational medicine 16 (738) (2024)
Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, Puja Bhavesh Patel, Daniel Fernández, Yan Wu, Chenzhou Hao, Chieh-Wen Lo, Marwah Karim, Lin Ning, Aimee Beck, Panatda Saenkham-Huntsinger, Vivian Tat, Aleksandra K Drelich, Bi-Hung Peng, Shirit Einav, Chien-Te Kent Tseng, Catherine A Blish, Michael Z Lin
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Science translational medicine 16 (738) (2024)
Tapas K Hazra, Nisha Tapryal, Anirban Chakraborty, Kempaiah Rayavara Kempaiah, Maki Wakamiya, Azharul Islam, Lang Pan, Jason Hsu, Vivian Tat, Junki Maruyama, Koa Hosoki, Ibrahim Sayed, Joshua Alcantara, Vanessa Castillo, Courtney Tindle, Altaf H Sarker, Victor Cardenas, Gulshan Sharma, Laura Crotty Alexander, Sanjiv Sur, Gourisankar Ghosh, Slobodan Paessler, Debashis Sahoo, Pradipta Ghosh, Soumita Das, Istvan Boldogh, Chien-Te Kent Tseng
The DNA glycosylase NEIL2 plays a vital role in combating SARS-CoV-2 infection. Research square (2022)
Rachel J Hagey, Menashe Elazar, Edward A Pham, Siqi Tian, Lily Ben-Avi, Claire Bernardin-Souibgui, Matthew F Yee, Fernando R Moreira, Meirav Vilan Rabinovitch, Rita M Meganck, Benjamin Fram, Aimee Beck, Scott A Gibson, Grace Lam, Josephine Devera, Wipapat Kladwang, Khanh Nguyen, Anming Xiong, Steven Schaffert, Talia Avisar, Ping Liu, Arjun Rustagi, Carl J Fichtenbaum, Phillip S Pang, Purvesh Khatri, Chien-Te Kent Tseng, Jeffery K Taubenberger, Catherine A Blish, Brett L Hurst, Timothy P Sheahan, Rachel J Hagey, Jeffrey S Glenn
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2. Nature medicine 28 (9) (2022)
Haley E Mudrick, Shane Massey, Erin B McGlinch, Brian J Parrett, Jack R Hemsath, Mary E Barry, Jeffrey D Rubin, Chisom Uzendu, Michael J Hansen, Courtney L Erskine, Virginia P Van Keulen, Aleksandra Drelich, Joseph A Panos, Madiha Fida, Gina A Suh, Tobias Peikert, Matthew S Block, Chien-Te Kent Tseng, Gloria R Olivier, Michael A Barry
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Science advances 8 (34) (2022)
Erol C Vatansever, Kai S Yang, Aleksandra K Drelich, Kaci C Kratch, Chia-Chuan Cho, Kempaiah Rayavara Kempaiah, Jason C Hsu, Drake M Mellott, Shiqing Xu, Chien-Te Kent Tseng, Wenshe Ray Liu
Bepridil is potent against SARS-CoV-2 in vitro. Proceedings of the National Academy of Sciences of the United States of America 118 (10) (2021)
Jingen Zhu, Neeti Ananthaswamy, Swati Jain, Himanshu Batra, Wei-Chun Tang, Douglass A Lewry, Michael L Richards, Sunil A David, Paul B Kilgore, Jian Sha, Aleksandra Drelich, Chien-Te Kent Tseng, Ashok K Chopra, Venigalla B Rao
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering. Science advances 7 (37) (2021)
Qibin Geng, Wanbo Tai, Victoria K Baxter, Juan Shi, Yushun Wan, Xiujuan Zhang, Stephanie A Montgomery, Sharon A Taft-Benz, Elizabeth J Anderson, Audrey C Knight, Kenneth H Dinnon Iii, Sarah R Leist, Ralph S Baric, Jian Shang, Sung-Wook Hong, Aleksandra Drelich, Chien-Te Kent Tseng, Marc Jenkins, Mark T Heise, Lanying Du, Fang Li
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection. PLoS pathogens 17 (9) (2021)
Xuping Xie, Antonio E Muruato, Xianwen Zhang, Kumari G Lokugamage, Camila R Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomas Cihlar, Chien-Te Kent Tseng, Shinji Makino, Vineet D Menachery, John P Bilello, Pei-Yong Shi
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature communications 12 (1) (2021)
Wei Li, Chuan Chen, Aleksandra K Drelich, David R Martinez, Lisa E Gralinski, Zehua Sun, Alexandra Schäfer, Swarali S Kulkarni, Xianglei Liu, Sarah R Leist, Doncho V Zhelev, Liyong Zhang, Ye-Jin Kim, Eric C Peterson, Alex Conard, John W Mellors, Chien-Te Kent Tseng, Darryl Falzarano, Ralph S Baric, Dimiter S Dimitrov
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 117 (47) (2020)
Xuping Xie, Antonio E Muruato, Xianwen Zhang, Kumari G Lokugamage, Camila R Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomas Cihlar, Chien-Te Kent Tseng, Shinji Makino, Vineet D Menachery, John P Bilello, Pei-Yong Shi
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature communications 11 (1) (2020)